Results of a Multicenter Phase II Study of Atezolizumab and Bevacizumab for Patients With Metastatic Renal Cell Carcinoma With Variant Histology and/or Sarcomatoid Features

PURPOSE: In this multicenter phase II trial, we evaluated atezolizumab combined with bevacizumab in patients with advanced renal cell carcinoma (RCC) with variant histology or any RCC histology with ≥ 20% sarcomatoid differentiation. PATIENTS AND METHODS: Eligible patients may have received previous...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: McGregor, Bradley A., McKay, Rana R., Braun, David A., Werner, Lillian, Gray, Kathryn, Flaifel, Abdallah, Signoretti, Sabina, Hirsch, Michelle S., Steinharter, John A., Bakouny, Ziad, Flippot, Ronan, Wei, Xiao X., Choudhury, Atish, Kilbridge, Kerry, Freeman, Gordon J., Van Allen, Eliezer M., Harshman, Lauren C., McDermott, David F., Vaishampayan, Ulka, Choueiri, Toni K.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2020
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7051851/
https://ncbi.nlm.nih.gov/pubmed/31721643
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.01882
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados